Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.390
+0.050 (2.14%)
At close: Apr 2, 2025, 4:00 PM
2.360
-0.030 (-1.26%)
After-hours: Apr 2, 2025, 6:32 PM EDT

Vistagen Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2015 - 2019
Market Capitalization
691432725630522
Upgrade
Market Cap Growth
-40.87%421.73%-89.32%-16.12%1309.99%-60.31%
Upgrade
Enterprise Value
-1818517621129
Upgrade
Last Close Price
2.395.283.7437.2063.9013.20
Upgrade
PS Ratio
104.84134.11-120.48230.95280.23-
Upgrade
PB Ratio
0.831.252.263.963.11-30.17
Upgrade
P/TBV Ratio
1.011.252.263.963.32-
Upgrade
EV/Sales Ratio
17.28-158.30193.50-
Upgrade
Debt / Equity Ratio
0.020.020.220.050.04-5.70
Upgrade
Asset Turnover
0.010.02-0.010.02-
Upgrade
Quick Ratio
9.2123.263.6411.8824.620.49
Upgrade
Current Ratio
9.3523.563.8312.3224.860.57
Upgrade
Return on Equity (ROE)
-46.28%-46.47%-154.30%-58.62%-36.78%-411.13%
Upgrade
Return on Assets (ROA)
-29.57%-28.52%-77.39%-32.65%-19.66%-131.43%
Upgrade
Return on Capital (ROIC)
-31.70%-31.46%-89.75%-35.19%-21.28%-182.29%
Upgrade
Earnings Yield
-68.58%-20.58%-216.63%-18.65%-5.87%-95.94%
Upgrade
FCF Yield
-56.76%-18.13%-182.55%-17.75%-4.04%-72.77%
Upgrade
Buyback Yield / Dilution
-126.55%-178.13%-5.45%-129.85%-96.34%-53.59%
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q